Recurrent morphoeic basal cell carcinoma with metastatic progression in a 34-year-old patient: a case report
Basal cell carcinomas (BCCs) are the most common type of cancer diagnosed in the world, predominantly affecting the head and neck region. However, metastatic BCCs are exceptionally rare, with an estimated prevalence between 0.0028% and 0.55%. We present a case of a young patient that demonstrates the highly aggressive nature of morphoeic BCC and the challenges in achieving long-term disease control despite multimodal therapy. The case data have been collected from The Christie Hospital NHS Foundation Trust and St Mary’s Regional Genetics Centre, Manchester, UK.
Authors
- Faisal R. Ali (ORCID: https://orcid.org/0000-0002-8588-791X)
- Usamah M Afzal (ORCID: https://orcid.org/0000-0002-8310-5750)
- John T. Lear (ORCID: https://orcid.org/0000-0002-2969-9922)
- Patrick Shenjere (ORCID: https://orcid.org/0000-0001-9627-6914)
- Deemesh Oudit
- Roxana Totorean
Institutions
- University of Lancashire (GB)
- Harrogate and District NHS Foundation Trust (GB)
- University of Manchester (GB)
- Health Biomed (China) (CN)
- The Christie NHS Foundation Trust (GB)
- NIHR Manchester Biomedical Research Centre (GB)
Publication Details
- Journal
- Clinical and Experimental Dermatology
- Published
- 2024-12-13
- DOI
- https://doi.org/10.1093/ced/llae537
- Primary Topic
- Nonmelanoma Skin Cancer Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00